Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Present status and perspective of pharmacogenetics in Mexico.

Drug metabolism and drug interactions - 1 Jan 2014

Cuautle-Rodríguez Patricia, Llerena Adrián, Molina-Guarneros Juan

Abstract excerpt

Drug costs account for up to 24% of the country's health expenditure and there are 13,000 registered drugs being prescribed. Diabetes is the main cause of death in the country, with over 85% of diabetic patients currently under drug treatment. The importance of knowing interindividual variability in drug metabolism on Mexican populations is thus evident. The purpose of this article is to provide an overlook of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Arylamine N-Acetyltransferase
Share to Biomedical Research
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Combinations

Share to Drug Costs

Share to Glycosyltransferases

Share to Mexican Americans

Share to Mexico

Source

Identifiers

PMID: 24129103
DOI: 10.1515/dmdi-2013-0019

Genes

NAT2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Present status and perspective of pharmacogenetics in Mexico.PMID 24129103Read ↗

Exploring the distribution of genetic markers of pharmacogenomics relevance in Brazilian and Mexican populations.Semantic proximity Read ↗

Evaluation of drug-metabolizing enzyme hydroxylation phenotypes in Hispanic populations: the CEIBA cocktail.Semantic proximity Read ↗

Exploring Variation in Known Pharmacogenetic Variants and its Association with Drug Response in Different Mexican Populations.Semantic proximity Read ↗

Pharmacogenetics of drug metabolizing enzymes in Brazilian populations.Semantic proximity Read ↗

Genomic biomarkers related to drug response in Venezuelan populations.Semantic proximity Read ↗

Simultaneous Determination of Cytochrome P450 Oxidation Capacity in Humans: A Review on the Phenotyping Cocktail Approach.Semantic proximity Read ↗

Pharmacogenetic Evaluation of Metformin and Sulphonylurea Response in Mexican Mestizos with Type 2 Diabetes.Semantic proximity Read ↗

Evaluation of important human CYP450 isoforms and P-glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after treatment, by using Geneva cocktailSemantic proximity Read ↗

Evaluation of important human CYP450 isoforms and P-glycoprotein phenotype changes and genotype in type 2 diabetic patients, before and after intensifying treatment regimen using Geneva cocktail.Semantic proximity Read ↗

Multiplex Phenotyping for Systems Medicine: A One-Point Optimized Practical Sampling Strategy for Simultaneous Estimation of CYP1A2, CYP2C9, CYP2C19, and CYP2D6 Activities Using a Cocktail Approach.Semantic proximity Read ↗

To Genotype or Phenotype for Personalized Medicine? CYP450 Drug Metabolizing Enzyme Genotype-Phenotype Concordance and Discordance in the Ecuadorian Population.Semantic proximity Read ↗

Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.